Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date 1978 | Founding Date 1897 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Basel, CH HQ Baulkham Hills, AU Antwerpen, BE Bornem, BE Verviers, BE Rio De Janeiro, BR Dorval, CA see more |
Employees | Employees 7,605 | Employees 19,7712% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) CHF6.5b (FY, 2025) |
Cost of goods | Cost of goods $2.4b (FY, 2025) | Cost of goods CHF2.1b (FY, 2025) |
Gross profit | Gross profit $7.5b (FY, 2025) | Gross profit CHF4.5b (FY, 2025) |
Net income | Net income $1.3b (FY, 2025) | Net income CHF909m (FY, 2025) |

Lonza Group is a company specializing in life sciences and biotechnology solutions
View company